Member Info for roger65

I did say yesterday I thought a placing might be coming soon. In terms of the dilution and even the price it’s not too bad but three things bother me now.

Why were existing share holders not given the opportunity to participate in the discounted placing?

An RNS released without any specifics on figures but clearly designed to cause a surge in the sp so the placees could forward sell and, to quote petroinvestor, leave existing share holders ‘holding the baby’ as the sp inevitably drops back to the placing price. Some big sellers yesterday who were clearly in the know. GST might be listed on the main market but the management certainly behave as if they’re running a company on AIM. It’s no wonder funding on LSE is drying up, causing more and more significant under valuations, when investors are so easily hoodwinked and ripped off.

If GST is now generating significant revenue why did they need a larger sum now than in the two previous placings? Why can the company not explain why the figures on GS 20 Exchange are so inaccurate? Why no figures at all?

Going on previous form were wrong receive Further news. Next RNS will be the acquisition and then the July results.

Shabby treatment of existing shares holders. We note move on and wait for some decent results. If on July those are disappointing then I’ll vote with my feet- and money. Only got £11k in here now but obviously less thanks to yesterday and today.

Thanks for a grown up post muminr . I’m glad I’m not the only one that waded through the whole discourse and came to a negative conclusion. I agree that the funding, the FDA partner, it’s all tied on the outcome of this NICE recommendation. Your reasoning for the outcome seems eminently plausible but GDR has seen many false dawns. Is this going to be another? Who knows. Either way Cheek is brave and playing for everything on this news. Time will tell.

Ell if you're in here too Metac.nt you'll be losing too very soon. Seems like I'm not the only one who didn't read the report...

And yet AHS here we are, a whopping 2%+ up. I agree it's ridiculous but something isn't right. There are some clever people out there who would see this as a huge opportunity to make very good money very quickly and yet people aren't piling in.

Tiger, you utter jerk. It’s a public consultation…. Find it on NICE website. You can see every comment made and then the response from the NICE panel. Nothing is hidden and not classified you idiot. Actually read it rather than just saying I’ve read it.

I think Gino was being disingenuous when he said he could see no reason why it wouldn’t granted Full recommendation. When I watched that presentation again the other day the person I was least convinced by was the CFO, who seemed reluctant to say anything and was clearly uncomfortable all the way through it

Yes i pressed the buy button but that was because we were being lied to. The management have not been open or honest about the dreadful state the company was in until it was too late for most investors to do anything about.

Charlatans. Nothing new for a company on AIM.

No, I know, but they are clearly anti

And just found this from NICE themselves -

This guidance is advisory and does not have a funding

mandate. NHS England may decide to consider

CYP2C19 genotype testing for inclusion in the National

Genomics Test Directory.

So even if they do approve use of CYP2C19 the NHS will still have the final say on if/where/when the test is used.

Inagene Diagnostics also very actively trying to sway opinion against using CYP2C19 suggesting it won't be cost effective long term as there will be newer tests arriving before long that can have much broader scope in what can be tested for.

Gulp....I've spent the last hour and a half reading the NICE consultation documents. I think CYP2C19 is highly unlikely to be given full recommendation. there are numerous other organisations who are clearly anti and suggesting there are better tests eg Mantara Health PGx DNA test which tests for 12 genes rather than just one that GDR test for on reaction to Clopidogrel, and also more cost effective treatments, mainly laboratory testing.

My mood just sank as i read more and more. I think Gino was not being entirely honest when he said in the presentation that he can see 'no reason' why Full recommendation would not be forthcoming. Blimey I've just read the whole thing and I can see there's a lot of opposition. Have to say I was also very disappointed by the lack of submitted evidence from GDR themselves. they only get involved on a handful of issues where as both Mantara and Genomadix are working hard to highlight all and any possible negatives by using the CYP2C19 test.

Flipping heck. I should have read this sooner but now I can see why the share price is going nowhere and yet the consultation period will end this Friday. Bugger Bugger Bugger. I will be amazed if GDR can survive now. If they can't get it to a point where even the NHS will use the test then no will want to buy GDR so there's not even a glimmer of hope that we might see a take over on the cheap. Apologies not to post more positive news. It's grim imv

Woody 'expects to complete the acquisition in Q2/Q3 2024'

Precisely. Q2 or Q3 ffs is only months away and yet retail investors want immediate gains these days or else they just f off and sit on the side lines waiting for an obvious certainty. Disappointed but I'm holding and jut waiting for something to pop

Blimey at the rate the sp is falling we'll end up the day red. ffs

Wait for good news for months and when it finally arrives the market just sells the news. Typical of UK markets at the moment. I guess this is why so many companies want to delist and get themselves listed in other countries. Come on GST get a shift on and give us some proper numbers.

There is no question the BOD would have made the most of any opportunity to arouse sentiment by suggesting FCA approval might be imminent. It wasn't even mentioned in today's corporate update so I think it's safe to say it's some way off still.

'as usual it is being controlled/manipulated .'

Not so sure about that. Other than at opening this hasn't been NT so it's just retail buying/selling and nothing more. Many i suspect are taking profits fully expecting the sp to drop back so they will be back at some point soon. It's telling that not a single ii is getting involved yet. That's when this will fly. Not even managed to hold on to a 10% rise. I'm very surprised.

Oh and mickey1223 you posted the following:

April 8th 'The company is about to go ballistic'

April 8th 'All will resume soon'

March 27th 'Just a technical glitch all going on at once'

'Back up and running soon'

27th March

'Just a technical glitch all going on at once'

'That RNS woke me up I have to say . Will all be fine.'

Poppy c.ck

This is from the recent RNS - 'The Fundraise, for which Shareholder approval is being sought, is necessary to avoid the Company being placed into administration'

the company has no money and will go bust if they don't succeed with this placing. the stock is now suspended. It's a great look and if you believe all the carp on here about the sp about to fly then you're a sandwich, basket and blanket short of a picnic. If there are investors seriously interested in this company and its potential why don't they just let it go bust and then pick it up for peanuts? Honestly some of the posting here is utterly shameless. If like me you have money tied up in this fiasco them I'm very much afraid you're about to lose it all. All the stuff on social media can be made up - it's not in an RNS and that means for AIM CEOs they can say whatever they like and retract it later or just say 'oops' they made a mistake. You see it all the time on AIM. Companies putting out messaging suggesting company growth, imminent contracts and positive outlooks etc etc and the very next thing out of the blue is announcing administration.

It's just not possible for a company to be telling the truth after such a dreadful period and decline in its share price of over 96% in just six months and all the recent legal proceedings that have all failed and an admission that they are totally broke and unless funded immediately, bringing with it absolutely massive dilution, that things are actually looking rosy and all is well. Lars has fu.ked up royally and lining this up to either be taken private or sold for peanuts or admin. He's just swindled about £150k out of retail punters to pay a few bills and get another month of salary cheques paid out but I reckon this second placing is a total sham. Could be wrong....

Cuckoo cuckoo...

'and we know they are making strong revenue from multiple sources'

no we don't, because the BOD won't confirm any figures. That's just wishful thinking. I would dearly like to know the levels of revenue at the moment but everything is hidden from view. GST is making money yes, we just have absolutely no idea how much and let's face it if they were making shed loads the professional investors and iis would be all over this like a rash. As things stand they aren't. Presumably because they too can't see what's really going on.

Hoping the BOD give a much clearer update soon. This one was good in terms of sentiment but it's given the p & d gangs another chance to make a quick few %. Wish we were sat at 2p!

About 9 or 10am tomorrow and we'll have a slightly better idea of what shenanigans are going on here, whether or not Lars has done the dirty or pulled off something incredible. I know where my money is - and there ain't anything I can do about it until the suspension is lifted. If it's lifted that is.

'and this is not financial advise'

ADVICE ADVICE ADVICE This is not financial ADVICE.

I would not ADVISE anyone to take your posts seriously Tiger. You've posted RNSs due any second for the last couple of weeks and there has been nothing, so it's fair to say most would rightly consider your 'opinions' as utter made up sh.te.

Yep looks like that massive sell has stymied today's rise. Not sure why someone would have sold even before the rise had got going though. Without it I think this would have been well over 1.5p by now. A 10% rise doesn't feel right for the news in that RNS. BODs haven't helped though by once again not being very clear with their comms. A $36m revenue contract is great but the market clearly doesn't buy it. they don't say for how long, how much profit they hope/expect to make per year so it's just too vague to carry any serious weight and give cause for a sustained rerate. Back to biting finger nails for another few months.

Still think another small raise is due about now. Last two were for about $750k and $850k I think? Another one with minimal dilution wouldn't be a bad thing and would provide a confidence boost that the acquisitions process is ongoing and leading us to the promised land....